During the past decade, Eastleigh Breast Care Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eastleigh Breast Care Centre" #1 collaborator was "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Eastleigh Breast Care Centre" are "Breast Cancer" (4 trials), "Early Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Eastleigh Breast Care Centre" in a lesser frequency.

Most popular intervention types in "Eastleigh Breast Care Centre" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Giredestrant" (2 trials), "LHRH Agonist" (2 trials), "Paclitaxel" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eastleigh Breast Care Centre" are 4 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Eastleigh Breast Care Centre". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Eastleigh Breast Care Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eastleigh Breast Care Centre, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".